3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Osteosarcoma
14
Sarcoma
10
Lymphoma
7
Dendritic Cell Sarcoma, Interdigitating
7
Burkitt Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
4
Leukemia
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Gastrointestinal Stromal Tumors
3
Central Nervous System Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Neoplasms
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Gliosarcoma
2
Glioblastoma
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Bile Duct Neoplasms
2
Appendiceal Neoplasms
2
Vipoma
1
Interventions
glucarpidase
2
ripretinib
1
gamma-Glutamyl Hydrolase
1
Zoledronic Acid
1
Methotrexate
1
Leucovorin
1
Carboxypeptidases
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
Leucovorin
×
Sarcoma
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts